Investigation of TSPO Variants in Schizophrenia and Antipsychotic Treatment Outcomes
Year: 2015
Type: article
Study design: Observational Study
Source: Pharmacogenomics
DOI: 10.2217/pgs.14.158
Authors: Jennie G Pouget, Vanessa F Gonçalves, Erika L Nurmi, Christopher P Laughlin, Karyn S Mallya, James T McCracken, Michael G Aman, Christopher J McDougle, Lawrence Scahill, Virginia L Misener, Arun K Tiwari, Clement C Zai, Eva J Brandl, Daniel Felsky, Amy Q Leung, Jeffrey A Lieberman, Herbert Y Meltzer, Steven G Potkin, Charlotte Niedling, Werner Steimer, Stefan Leucht, Jo Knight, Daniel J Müller, James L Kennedy
Institutions: Centre for Addiction and Mental Health, University of Toronto, Campbell Family Mental Health Research Institute, University of California, Los Angeles, The Ohio State University, Massachusetts General Hospital, Emory University, Charité – Universitätsmedizin Berlin, New York State Psychiatric Institute, Columbia University, Northwestern University, University of California, Irvine, TUM Klinikum, Technical University of Munich
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1963555631